Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK0529 for RSV bronchiolitis in infants
CTR20200215Phase 3Completed
- Sponsor
- Aicobio
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziresovir in respiratory syncytial virus disease (RSV), viral bronchiolitis, sponsored by Aicobio. Started Feb 2020; status: completed.
02
Drugs
ziresovir
03
Conditions
respiratory syncytial virus disease (RSV)viral bronchiolitis
Beyond the preview
Go deeper on CTR20200215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200215.